Molle, K. D.; Chedotal, A.; Rao, Y.; Lumsden, A.; Wizenmann, A.: Local inhibition guides the trajectory of early longitudinal tracts in the developing chick brain. Mechanisms of Development 121 (2), pp. 143 - 156 (2004)

Kawakami, N.; Lassmann, S.; Li, Z. X.; Odoardi, F.; Ritter, T.; Ziemssen, T.; Klinkert, W. E. F.; Ellwart, J. W.; Bradl, M.; Krivacic, K. et al.; Lassmann, H.; Ransohoff, R. M.; Volk, H. D.; Wekerle, H.; Linington, C.; Flügel, A.: The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. Journal of Experimental Medicine 199 (2), pp. 185 - 197 (2004)

Banati, R. B.; Egensperger, R.; Maassen, A.; Hager, G.; Kreutzberg, G. W.; Graeber, M. B.: Mitochondria in activated microglia in vitro. Journal of Neurocytology 33 (5), pp. 535 - 541 (2004)

Bohatschek, M.; Kloss, C. U. A.; Pfeffer, K.; Bluethmann, H.; Raivich, G.: B7.2 on activated and phagocytic microglia in the facial axotomy model: Regulation by interleukin-1 receptor type 1, tumor necrosis factor receptors 1 and 2 and endotoxin. Journal of Neuroimmunology 156 (1-2), pp. 132 - 145 (2004)

Carandini, M.; Sengpiel, F.: Contrast invariance of functional maps in cat primary visual cortex. Journal of Vision 4 (3), pp. 130 - 143 (2004)

Clanet, M.; Kappos, L.; Hartung, H. P.; Hohlfeld, R.; The European IFNβ-1a Dose Comparison Study Investigators: Interferon β-1a in relapsing multiple sclerosis: Four-year extension of the European IFNβ-1a Dose Comparison Study. Multiple Sclerosis Journal 10, pp. 139 - 144 (2004)

Grunwald, I. C.; Korte, M.; Adelmann, G.; Plueck, A.; Kullander, K.; Adams, R. H.; Frotscher, M.; Bonhoeffer, T.; Klein, R.: Hippocampal plasticity requires postsynaptic ephrinBs. Nature Neuroscience 7 (1), pp. 33 - 40 (2004)

Guggenmos, J.; Schubart, A. S.; Ogg, S.; Andersson, M.; Olsson, T.; Mather, I. H.; Linington, C.: Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. Journal of Immunology 172 (1), pp. 661 - 668 (2004)

Hohlfeld, R.: Immunologic factors in primary progressive multiple sclerosis. Multiple Sclerosis 10, pp. 16 - 22 (2004)

Karrasch, T.; Weil, M.; Voltz, R.; Schulz, C.; Audebert, F.; Woenckhaus, M.; Hofstädter, F.; Bogdahn, U.; Scholmerich, J.; Schäffler, A. et al.; Steinbrecher, A.: "Fußkribbeln", Vergesslichkeit und progrediente Wesensveränderung bei einer 63-jährigen Patientin. Internist 45 (3), pp. 341 - 346 (2004)

Korte, M.: Tag- und Nachtgeschichten, in: Die Reduktion frisst ihre Kinder: Zum Umgang mit komplexen Themen. Gegenworte 13, pp. 24 - 29 (2004)

Kreutzberg, G.: Kurze Geschichte der Regeneration im Nervensystem. Neuroforum 1, pp. 163 - 168 (2004)

Kreutzberg, G. W.: Hat der Mensch (k)einen freien Willen? Regeneration 24, p. 10 - 10 (2004)

Liliensiek, B.; Weigand, M. A.; Bierhaus, A.; Nicklas, W.; Kasper, M.; Hofer, S.; Plachky, J.; Grone, H. J.; Kurschus, F. C.; Schmidt, A. M. et al.; Yan, S. D.; Martin, E.; Schleicher, E.; Stern, D. M.; Hammerling, G. G.; Nawroth, P. P.; Arnold, B.: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. Journal of Clinical Investigation 113 (11), pp. 1641 - 1650 (2004)

Linke, R.; Schröder, M.; Helmberger, T.; Voltz, R.: Antibody-positive paraneoplastic neuroligical syndromes: The value of CT and FDG-PET imaging for tumor diagnosis. Neurology 63 (2), pp. 282 - 286 (2004)

Mead, R. J.; Neal, J. W.; Griffiths, M. R.; Linington, C.; Botto, M.; Lassmann, H.; Morgan, B. P.: Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis. Laboratory Investigation 84 (1), pp. 21 - 28 (2004)

Meinl, E.; Voltz, R.: Biomarker in der Therapie der Multiplen Sklerose: Läßt sich der Erfolg bald vorhersagen? MMW-Fortschr. Med. Sonderheft 2, p. 517 - 517 (2004)

Pfister, H.; Ollert, M.; Fröhlich, L. O.; Quintanilla-Fend, L.; Colby, T. V.; Specks, U.; Jenne, D. E.: Autoantibodies against the murine homolog of Wegener’s autoantigen (proteinase 3) are pathogenic in vivo. Blood 104, pp. 1411 - 1418 (2004)

Schweigreiter, R.; Walmsley, A. R.; Niederost, B.; Zimmermann, D. R.; Oertle, T.; Casademunt, E.; Frentzel, S.; Dechant, G.; Mir, A.; Bandtlow, C. E.: Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75(NTR)/NgR-independent pathways that converge at RhoA. Molecular and Cellular Neuroscience 27 (2), pp. 163 - 174 (2004)

Seidl, A. H.; Grothe, B.: Development of sound localization in mammals is shaped by early acoustic experience. Journal of Neurophysiology (2004)